12 found
Order:
Disambiguations
Anne Lederman Flamm [10]Anne L. Flamm [7]
  1.  25
    Developing and Testing a Checklist to Enhance Quality in Clinical Ethics Consultation.Martin L. Smith, Ruchi Sanghani, Anne Lederman Flamm, Margot M. Eves, Susannah L. Rose & Lauren Sydney Flicker - 2014 - Journal of Clinical Ethics 25 (4):281-290.
    Checklists have been used to improve quality in many industries, including healthcare. The use of checklists, however, has not been extensively evaluated in clinical ethics consultation. This article seeks to fill this gap by exploring the efficacy of using a checklist in ethics consultation, as tested by an empirical investigation of the use of the checklist at a large academic medical system (Cleveland Clinic). The specific aims of this project are as follows: (1) to improve the quality of ethics consultations (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   11 citations  
  2.  21
    Family Members’ Requests to Extend Physiologic Support after Declaration of Brain Death: A Case Series Analysis and Proposed Guidelines for Clinical Management.Patricia A. Mayer, Martin L. Smith & Anne Lederman Flamm - 2014 - Journal of Clinical Ethics 25 (3):222-237.
    We describe and analyze 13 cases handled by our ethics consultation service (ECS) in which families requested continuation of physiological support for loved ones after death by neurological criteria (DNC) had been declared. These ethics consultations took place between 2005 and 2013. Patients’ ages ranged from 14 to 85. Continued mechanical ventilation was the focal intervention sought by all families. The ECS’s advice and recommendations generally promoted “reasonable accommodation” of the requests, balancing compassion for grieving families with other ethical and (...)
    Direct download  
     
    Export citation  
     
    Bookmark   7 citations  
  3.  46
    Accommodating Religious Beliefs in the ICU: A Narrative Account of a Disputed Death.Martin L. Smith & Anne Lederman Flamm - 2011 - Narrative Inquiry in Bioethics 1 (1):55-64.
    Conflicts of interest. None to report. Despite widespread acceptance in the United States of neurological criteria to determine death, clinicians encounter families who object, often on religious grounds, to the categorization of their loved ones as “brain dead.” The concept of “reasonable accommodation” of objections to brain death, promulgated in both state statutes and the bioethics literature, suggests the possibility of compromise between the family’s deeply held beliefs and the legal, professional and moral values otherwise directing clinicians to withdraw medical (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  4.  62
    Revisiting Ethical Guidelines for Research with Terminal Wean and Brain‐Dead Participants.Rebecca D. Pentz, Anne L. Flamm, Renata Pasqualini, Christopher J. Logothetis & Wadih Arap - 2003 - Hastings Center Report 33 (1):20-26.
    Some research is too risky to be conducted on anyone whose life expectancy is more than a few hours. Yet sometimes, the research can still be carried out using subjects who are brain dead or are soon to undergo a terminal wean, and who have articulated values that inclusion in the study can honor. So argues a team of ethicists and researchers at M.D. Anderson Cancer Center, where such research was recently undertaken.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  5.  11
    Developing effective ethics policy.Anne Lederman Flamm - 2012 - In D. Micah Hester & Toby Schonfeld, Guidance for healthcare ethics committees. Cambridge, UK: Cambridge University Press.
    Direct download  
     
    Export citation  
     
    Bookmark   2 citations  
  6.  25
    Medical research and media circuses.Anne Lederman Flamm - 2004 - Hastings Center Report 34 (1):3-3.
    Direct download  
     
    Export citation  
     
    Bookmark   3 citations  
  7.  14
    Empirical Bioethics Research Is a Winner, But Bioethics Mission Creep Is a False Alarm.Eric Kodish & Anne Lederman Flamm - 2014 - Journal of Clinical Ethics 25 (3):189-193.
    While we do not share Evans’s view that social science research is needed to shield bioethics from competitive threat, we incorporate and engage in social science research to inform our knowledge base, our clinical practice, and our contributions to the ongoing development of the field.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  8.  37
    Define "Effective": The Curious Case of Chronic Cancer.Nancy Berlinger & Anne Lederman Flamm - 2009 - Hastings Center Report 39 (6):17-20.
  9.  60
    Elizabeth Mitchell Armstrong is asso.Nancy Berlinger, Pauline W. Chen, Rebecca Dresser, Nancy Neveloff Dubler, Anne Lederman Flamm, Susan Gilbert, Mark A. Hall & Lisa H. Harris - forthcoming - Hastings Center Report.
  10.  22
    Fees Can't Build Good Fences.Anne Lederman Flamm - 2012 - Hastings Center Report 42 (1):13-14.
    To sustain its serene environment, YourTown, USA—which is a real town—enacted a policy designed to abate public nuisances occurring on residential properties. The nuisance ordinance authorizes the police chief, after two incidents within a twelve‐month period in which criminal activity nuisances have occurred on a property, to warn owners in writing that a third incident may result in an order to pay fees. The third finding authorizes YourTown to “abate the nuisance by responding to the activities using administrative and law (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  11.  9
    (6 other versions)Legal Trends in Bioethics.Anne L. Flamm - 2001 - Journal of Clinical Ethics 12 (4):415-426.
    Direct download  
     
    Export citation  
     
    Bookmark  
  12.  34
    Who Should Go First in Trials with Scarce Agents? the Views of Potential Participants.Rebecca D. Pentz, Anne L. Flamm, Jeremy Sugarman, Marlene Z. Cohen, Zhiheng Xu, Roy S. Herbst & James L. Abbruzzese - 2007 - IRB: Ethics & Human Research 29 (4):1.
    Access to investigational drugs is a concern to patients and regulatory agencies. In order to determine potential trial participants’ views on access to investigational drugs, we surveyed one hundred people who had been referred to a phase I clinical trial. Most respondents indicated that patients had a right to investigational drugs, that the drugs should be offered only in the context of research, that getting access to these drugs is too hard, and that knowing the right people and being persistent (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark